Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Holdings
Biotech
Asceneuron raises $100M series C for ph. 2 Alzheimer's trial
With the first wave of Alzheimer’s drugs reaching the market, investors are seeking the next big advance in this red-hot area of neuroscience R&D.
James Waldron
Jul 16, 2024 3:00am
Myricx secures $114M series A to push ADCs into clinic
Jul 8, 2024 1:00am
Reunion nets $103M, one of the largest for a psychedelic biotech
May 2, 2024 6:30am
Third Rock, Novo Holdings-backed Clasp hooks $150M series A
Mar 20, 2024 7:00am
Next-gen PSA test maker Cleveland Dx rocks to $75M fundraising
Jan 29, 2024 11:07am
Novo Holdings plans to ramp up dealmaking amid Wegovy windfall
Jan 19, 2024 9:30am